Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy
Aziz Zaanan, Jean François Flejou, Jean François Emile, Gaëtan Des Guetz, Peggy Cuilliere-Dartigues, David Malka, Cedric Lecaille, Pierre Validire, Christophe Louvet, Philippe Rougier, Aimery De Gramont, Franck Bonnetain, Françoise Praz, Julien Taïeb
Research output: Contribution to journal › Article › peer-review
76Scopus
citations
Fingerprint
Dive into the research topics of 'Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy'. Together they form a unique fingerprint.